NeutriSci International Inc. (NRXCF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
NeutriSci International Inc. (NRXCF) with AI Score 56/100 (Hold). NeutriSci International Inc. develops and distributes nutraceutical products, including its flagship neuenergy tablet, across multiple continents. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 15, 2026NeutriSci International Inc. (NRXCF) Healthcare & Pipeline Overview
NeutriSci International Inc. operates in the nutraceuticals market, developing and distributing products like neuenergy across North America, Europe, and Asia. With a focus on energy and mental clarity, the company utilizes retail and online channels, facing competition in a fragmented and evolving market landscape.
Investment Thesis
Investing in NeutriSci International Inc. presents a high-risk, high-reward scenario. The company's negative gross margin of -9.5% and profit margin of -168.4% raise concerns about its financial sustainability. The company's success hinges on its ability to achieve significant revenue growth and improve its cost structure. Potential catalysts include successful expansion into new markets and the launch of additional nutraceutical products. However, the company's reliance on partnerships and the competitive nature of the nutraceuticals market pose significant risks. The negative beta of -0.83 suggests that the stock moves inversely to the market, which could provide some downside protection during market downturns, but also limit upside potential during bull markets. Investors should closely monitor the company's financial performance and market execution to assess its long-term viability.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $0.00B indicates a micro-cap company with limited resources and higher volatility.
- P/E Ratio of -1.08 suggests the company is currently unprofitable, making traditional valuation difficult.
- Profit Margin of -168.4% highlights significant challenges in achieving profitability and managing expenses.
- Gross Margin of -9.5% indicates that the cost of goods sold exceeds revenue, raising concerns about pricing and production efficiency.
- Beta of -0.83 suggests the stock has a negative correlation with the market, potentially offering some downside protection during market downturns.
Competitors & Peers
Strengths
- Established distribution network in multiple countries.
- Proprietary formulation for neuenergy.
- Partnerships with other companies in the health and wellness industry.
- Focus on a growing market segment (energy and mental clarity).
Weaknesses
- Negative gross and profit margins.
- Limited financial resources.
- Dependence on partnerships for distribution.
- Small market capitalization.
Catalysts
- Upcoming: Potential expansion into new geographic markets, such as Asia and South America, by the end of 2026.
- Upcoming: Launch of new nutraceutical products targeting different health and wellness needs in Q4 2026.
- Ongoing: Strategic partnerships with complementary businesses to expand reach and access new markets.
- Ongoing: Increased online sales through e-commerce platforms and digital marketing initiatives.
- Ongoing: Development of innovative nutraceutical formulations with proprietary ingredients.
Risks
- Ongoing: Intense competition in the nutraceuticals market from established brands and emerging players.
- Potential: Changing consumer preferences and regulatory requirements affecting product demand and compliance.
- Potential: Supply chain disruptions impacting the availability and cost of raw materials.
- Potential: Economic downturn affecting consumer spending on discretionary items like nutraceuticals.
- Ongoing: The company's negative gross and profit margins raise concerns about its financial sustainability.
Growth Opportunities
- Expansion into New Geographies: NeutriSci has the opportunity to expand its distribution network into new geographic markets, particularly in Asia and South America, where demand for nutraceutical products is growing. By establishing partnerships with local distributors and tailoring its product offerings to meet regional preferences, NeutriSci can tap into new revenue streams and diversify its customer base. This expansion could increase revenue by an estimated 20% within the next three years.
- Product Line Diversification: NeutriSci can expand its product line beyond neuenergy to include other nutraceutical products targeting different health and wellness needs. By developing and launching new products in categories such as immune support, digestive health, and sleep enhancement, NeutriSci can attract a broader range of customers and increase its market share. This diversification could lead to a 15% increase in revenue within the next two years.
- Strategic Partnerships: NeutriSci can leverage strategic partnerships with other companies in the health and wellness industry to expand its reach and access new markets. By collaborating with complementary businesses, such as fitness centers, health food stores, and online retailers, NeutriSci can increase its brand awareness and distribution capabilities. These partnerships could contribute to a 10% increase in revenue within the next year.
- Online Sales Growth: NeutriSci can focus on growing its online sales channels through e-commerce platforms and digital marketing initiatives. By investing in search engine optimization (SEO), social media marketing, and targeted advertising, NeutriSci can reach a wider audience and drive online sales. This strategy could result in a 25% increase in online revenue within the next two years.
- Development of Innovative Formulations: NeutriSci can invest in research and development to create innovative nutraceutical formulations that address specific health concerns and provide unique benefits to consumers. By developing proprietary ingredients and delivery systems, NeutriSci can differentiate its products from competitors and attract health-conscious consumers. This innovation could lead to a 20% increase in revenue within the next three years.
Opportunities
- Expansion into new geographic markets.
- Product line diversification.
- Increased online sales through e-commerce platforms.
- Development of innovative nutraceutical formulations.
Threats
- Intense competition in the nutraceuticals market.
- Changing consumer preferences and regulatory requirements.
- Potential supply chain disruptions.
- Economic downturn affecting consumer spending on discretionary items.
Competitive Advantages
- Proprietary formulations for neuenergy.
- Established distribution network in multiple countries.
- Partnerships with LaSanta Botanicals, Nutritional High, and Naturally Splendid.
- Brand recognition in the energy supplement market.
About NRXCF
NeutriSci International Inc., established in 2009 and headquartered in Vancouver, Canada, is a nutraceutical company engaged in the development, marketing, and distribution of health and wellness products. The company's flagship product, neuenergy, is an energy tablet designed to enhance focus and mental clarity. NeutriSci distributes its products through a network of retail and online channels, targeting consumers in Canada, the United States, Europe, Asia, and South America. The company has established partnerships with LaSanta Botanicals, Nutritional High, and Naturally Splendid to expand its market reach and product offerings. NeutriSci operates in the competitive nutraceuticals market, which includes a wide range of dietary supplements and functional foods. The company aims to differentiate itself through innovative product formulations and effective distribution strategies. However, the company's negative gross and profit margins indicate potential challenges in achieving profitability and sustainable growth.
What They Do
- Develops nutraceutical products.
- Markets nutraceutical products.
- Distributes nutraceutical products.
- Offers neuenergy, an energy tablet for focus and mental clarity.
- Sells products through retail channels.
- Sells products through online channels.
Business Model
- Develops and manufactures nutraceutical products.
- Distributes products through retail and online channels.
- Generates revenue through product sales.
- Partners with other companies for distribution and product development.
Industry Context
NeutriSci International Inc. operates within the global nutraceuticals market, which is characterized by increasing consumer interest in health and wellness products. The market includes dietary supplements, functional foods, and beverages. Competition is intense, with numerous players ranging from large multinational corporations to smaller, specialized companies. NeutriSci's success depends on its ability to differentiate its products, establish strong distribution channels, and effectively market its offerings. The company faces competition from established brands and emerging players, requiring continuous innovation and adaptation to changing consumer preferences.
Key Customers
- Individuals seeking enhanced focus and mental clarity.
- Consumers interested in health and wellness products.
- Retailers selling nutraceutical products.
- Online consumers purchasing health supplements.
Financials
Chart & Info
NeutriSci International Inc. (NRXCF) stock price: Price data unavailable
Latest News
No recent news available for NRXCF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NRXCF.
Price Targets
Wall Street price target analysis for NRXCF.
MoonshotScore
What does this score mean?
The MoonshotScore rates NRXCF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Glen Rehman
CEO
Glen Rehman serves as the CEO of NeutriSci International Inc. His background includes experience in the nutraceuticals and consumer packaged goods industries. He has held various leadership positions in sales, marketing, and operations, focusing on driving revenue growth and expanding market share. Rehman's expertise lies in developing and executing strategic plans, building strong teams, and fostering innovation. He is committed to delivering high-quality products and services to customers and creating value for shareholders.
Track Record: Under Glen Rehman's leadership, NeutriSci International Inc. has focused on expanding its distribution network and developing new nutraceutical products. Key milestones include establishing partnerships with LaSanta Botanicals, Nutritional High, and Naturally Splendid. Rehman has also overseen the company's efforts to increase its online sales and brand awareness. However, the company's financial performance, particularly its negative gross and profit margins, remains a challenge.
NRXCF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that NeutriSci International Inc. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies on this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and potential for fraud or manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing in these companies.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Potential for price manipulation and fraud.
- Higher risk of delisting or going out of business.
- Lack of regulatory oversight compared to major exchanges.
- Verify the company's financial statements and audit reports.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Review the company's legal and regulatory filings.
- Evaluate the company's capital structure and debt levels.
- Determine the company's ownership structure and insider holdings.
- Consult with a qualified financial advisor before investing.
- Company has been in operation since 2009.
- Partnerships with LaSanta Botanicals, Nutritional High, and Naturally Splendid.
- Distribution network in multiple countries.
- Development and marketing of neuenergy product.
NeutriSci International Inc. Stock: Key Questions Answered
What does NeutriSci International Inc. do?
NeutriSci International Inc. is a nutraceutical company that develops, markets, and distributes health and wellness products. Its primary offering is neuenergy, an energy tablet designed to enhance focus and mental clarity. The company operates through a distribution network of retail and online channels, targeting consumers in Canada, the United States, Europe, Asia, and South America. NeutriSci also forms partnerships with other companies, such as LaSanta Botanicals and Nutritional High, to expand its market reach and product offerings within the competitive nutraceuticals industry.
What do analysts say about NRXCF stock?
Currently, there is no readily available analyst coverage for NRXCF stock due to its OTC Other listing and small market capitalization. This lack of analyst coverage makes it difficult to obtain consensus estimates or valuation targets. Investors should rely on their own independent research and due diligence to assess the company's prospects and risks. Key metrics to consider include revenue growth, gross margin, profitability, and cash flow. The absence of analyst opinions adds to the risk profile of this investment.
What are the main risks for NRXCF?
The main risks for NeutriSci International Inc. include intense competition in the nutraceuticals market, changing consumer preferences, and regulatory requirements. The company's negative gross and profit margins raise concerns about its financial sustainability. As an OTC-listed company, NRXCF faces liquidity risks and limited financial disclosure. Dependence on partnerships for distribution and potential supply chain disruptions also pose challenges. Investors should carefully consider these risks before investing in NRXCF.
What are the key factors to evaluate for NRXCF?
NeutriSci International Inc. (NRXCF) currently holds an AI score of 56/100, indicating moderate score. Key strength: Established distribution network in multiple countries.. Primary risk to monitor: Ongoing: Intense competition in the nutraceuticals market from established brands and emerging players.. This is not financial advice.
How frequently does NRXCF data refresh on this page?
NRXCF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven NRXCF's recent stock price performance?
Recent price movement in NeutriSci International Inc. (NRXCF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established distribution network in multiple countries.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider NRXCF overvalued or undervalued right now?
Determining whether NeutriSci International Inc. (NRXCF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying NRXCF?
Before investing in NeutriSci International Inc. (NRXCF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited due to the company's OTC listing.
- Analyst coverage is not available for this stock.
- Information is based on publicly available sources.